These data suggest PCA3 expression may be indicating two distinct differentiation cellular or tissue states within the prostate tumor; an early state where high levels of PCA3 are detectable and a second, late stage state where PCA3 levels decline. The gene discussed is PCA3; the disease is prostate neoplasm.